Cargando…

Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding

Welsh immunodeficient patients on immunoglobulin replacement therapy (IgRT) who were considered high risk for severe coronavirus disease 2019 (COVID-19) were directed to shield. Consequently, patients receiving hospital-based intravenous immunoglobulin (IVIg) quickly transitioned to home-based self-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgan, Clare, Jolles, Stephen, Ponsford, Mark J., Evans, Kimberly, Carne, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	PRIMARY IMMUNE DEFICIENCY DISEASE: Edited by M. Teresa de la Morena and Stephen Jolles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612677/ https://www.ncbi.nlm.nih.gov/pubmed/36165464 http://dx.doi.org/10.1097/ACI.0000000000000864

Ejemplares similares

Global immunoglobulin supply: steaming towards the iceberg?
por: Prevot, Johan, et al.
Publicado: (2020)

Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021)

Updates of cancer hallmarks in patients with inborn errors of immunity
por: Wang, Yating, et al.
Publicado: (2022)

Dendritic cell analysis in primary immunodeficiency
por: Bigley, Venetia, et al.
Publicado: (2016)

Atopic manifestations of inborn errors of immunity
por: Sams, Laura, et al.
Publicado: (2023)

An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex
por: Kracker, Sven, et al.
Publicado: (2015)

Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches
por: Tessarin, Giulio, et al.
Publicado: (2023)

Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency()
por: Hassan, Amel, et al.
Publicado: (2014)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
por: Jolles, Stephen
Publicado: (2013)

When less is more: primary immunodeficiency with an autoinflammatory kick
por: Giannelou, Angeliki, et al.
Publicado: (2014)

Lymphocyte subsets in healthy Malawians: Implications for immunologic assessment of HIV infection in Africa
por: Mandala, Wilson L., et al.
Publicado: (2010)

Pattern recognition receptor-mediated cytokine response in infants across 4 continents(⋆)()
por: Smolen, Kinga K., et al.
Publicado: (2014)

Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency
por: Lang, Philipp A., et al.
Publicado: (2013)

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
por: Castiello, Maria Carmina, et al.
Publicado: (2015)

Effects of maternal geohelminth infections on allergy in early childhood
por: Cooper, Philip J., et al.
Publicado: (2016)

Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
por: Cetica, Valentina, et al.
Publicado: (2015)

Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry
por: Cetica, Valentina, et al.
Publicado: (2016)

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
por: Coulter, Tanya I., et al.
Publicado: (2017)

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
por: Chen, Hannah H., et al.
Publicado: (2017)

Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
por: Stier, Matthew T., et al.
Publicado: (2016)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
por: Ponsford, Mark J., et al.
Publicado: (2022)

Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
por: Lum, S. H., et al.
Publicado: (2019)

Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency
por: Slatter, Mary A., et al.
Publicado: (2020)

Transition of care in inborn errors of immunity
por: Tadros, Susan, et al.
Publicado: (2023)

Advances in gene therapy for inborn errors of immunity
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)

A New Light on Vitamines
Publicado: (1921)

Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency
por: Anker, Stefan D., et al.
Publicado: (2022)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review
por: Walter, Graham, et al.
Publicado: (2020)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, A, et al.
Publicado: (2013)

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, Adriana, et al.
Publicado: (2012)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

TRAUMATIC “ANGIOEDEMA”: EXTENSIVE SUBCUTANEOUS EMPHYSEMA MASQUERADING AS ANGIOEDEMA
por: Khakwani, Z., et al.
Publicado: (2022)

Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients
por: Bienvenu, Boris, et al.
Publicado: (2018)

Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies
por: Mallick, Rajiv, et al.
Publicado: (2018)

A Criticism of the New Nomenclature
Publicado: (1914)

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study
por: Schmidt, C., et al.
Publicado: (2016)

Report of the General Board for Scotland
Publicado: (1920)

Cannot write session to /tmp/vufind_sessions/sess_n6eq3obe2uvsudu2bvr8ouslfj